Revised FIGO staging for carcinoma of the cervix uteri
Neerja Bhatla(National Institute of Immunology), Rengaswamy Sankaranarayanan(Centre International de Recherche sur le Cancer), Jonathan S. Berek(Stanford Health Care), Ikuo Konishi(Kyoto Medical Center), Lynette Denny(South African Medical Research Council), Kanishka Karunaratne(University of Colombo), Mauricio Cuello Fredes(Pontificia Universidad Católica de Chile), Alexander Olawaiye(Magee-Womens Hospital), Seija Grénman(University of Turku), Jaime Prat(Hospital de Sant Pau), Sean Kehoe(University College Birmingham)
Cited by 1,024
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix
|Journal of Clinical Oncology|2000|2.3k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Cancer of the cervix uteri
|International Journal of Gynecology & Obstetrics|2018|1.1k